TSFM mutations cause a complex hyperkinetic movement disorder with strong relief by cannabinoids.

01. März, 2019

Andreas Traschütz 1, Stefanie N Hayer 1, Benjamin Bender 2, Ludger Schöls 1, Saskia Biskup 3, Matthis Synofzik 4.

Abstract

No abstract available

Keywords: Cannabinoids; Chorea; Hyperkinetic movement disorders; Leigh syndrome; Mitochondrial; Subthalamic nucleus..

  1. Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research & Center of Neurology, University of Tuebingen, Tuebingen, Germany; German Research Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany.
  2. Department of Diagnostic and Interventional Neuroradiology, University Hospital Tuebingen, Tuebingen, Germany.
  3. Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research & Center of Neurology, University of Tuebingen, Tuebingen, Germany; CeGaT GmbH, Center for Genomics and Transcriptomics, Paul-Ehrlich-Str. 23, 72076 Tübingen, Germany.
  4. Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research & Center of Neurology, University of Tuebingen, Tuebingen, Germany; German Research Center for Neurodegenerative Diseases (DZNE), University of Tuebingen, Tuebingen, Germany. Electronic address: matthis.synofzik@uni-tuebingen.de.